News Alimentiv Experts Share Latest Advancements in GI Clinical Trials at DDW 2025 April 23, 2025 – Alimentiv Inc. (“Alimentiv”) is pleased to announce its participation in the highly anticipated Digestive Disease Week (DDW), taking place May 3–6, 2025 in San Diego, California. DDW 2025 is the largest and most prestigious gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. This year, Alimentiv medical experts will showcase poster and oral presentations covering a variety of innovative GI research, including Crohn’s disease, ulcerative colitis, and more. The Alimentiv team will be available to discuss your clinical studies and the following posters and presentations: Improvement in biomarkers in patients with ulcerative colitis treated with vedolizumab: Results from the continuing VERDICT trialPresenter: Dr. Vipul Jairath Placebo rates in randomized clinical trials of ulcerative colitis: An individual patient data meta-analysisPresenter: Dr. Virginia Solitano Development, internal, and external validation of a novel endoscopic activity score for evaluation of Crohn’s disease (EASE-CD)Presenter: Dr. Christopher Ma Target achievement after 48 weeks of vedolizumab treatment in patients with moderate to severe ulcerative colitis: An interim analysis from the VERDICT trialPresenter: Dr. Vipul Jairath See the full schedule. Connect with Alimentiv’s experts at booth #4549 and discover how we can help you achieve your project goals.